The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings

Archives of Medical Science

Volumn 12, Issue 6, 2016, Pages 1263-1272

  Kieszko, Robert ^a   Krawczyk, Pawel ^a   Powrozek, Tomasz ^a   Szudy Szczyrek, Aneta ^a   Szczyrek, Michał ^a   Homa, Iwona ^a   Daniluk, Jadwiga ^a,b   Milanowski, Janusz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Technical University of Biala Podlaska   (Poland)

Author keywords

Ace gene; Environment; Polymorphism; Sarcoidosis; T lymphocytes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ACE GENE; ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DNA DETERMINATION; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INCIDENCE; LABORATORY TEST; LEUKOCYTE; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MIDDLE AGED; PHENOTYPE; POLLUTION; RISK ASSESSMENT; SEX DIFFERENCE; URBAN RURAL DIFFERENCE; URBANIZATION;

EID: 84992730324     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2015.48966     Document Type: Article

References (38)

1. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 2007; 28: 22-35.
2. Sharma OP. Sarcoidosis around the world. Clin Chest Med 2008; 29: 357-63.
3. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-30.
4. Ding Q, Cao C, Chen Z, Tabusi M, Chen L, Deng Z. A functional EGF+61 polymorphism is associated with severity of obstructive sleep apnea. Sleep Breath 2014; DOI10.1007/s11325-014-1035-4.
5. Wu Y, Cao C, Wu Y, et al. TNF-Alpha-308G/A Polymorphism contributes to obstructive sleep apnea syndrome risk: Evidence based on 10 case-control studies. PLoS One 2014; 9: E106183.
6. Foley PJ, Lympany PA, Puscinska E, Zielinski J, Welsh KI, du Bois RM. Analysis of MHC encoded antygen - processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Rep Crit Care Med 1999; 160: 1009-14.
7. Hizawa N, Yamaguchi E, Furuya K, Jinushi E, Ito A, Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999; 159: 2021-3.
8. Kieszko R, Krawczyk P, Chocholska S, Dmoszynska A, Milanowski J. TNF-Alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 131-7.
9. Kurowski M, Majkowska-Wojciechowska B, Wardzynska A, Kowalski ML. Associations of allergic sensitization and clinical phenotypes with innate immune response genes polymorphisms are modified by house dust mite allergen exposure. Arch Med Sci 2011; 7: 1029-36.
10. Coates D. The angiotensin converting enzyme (ACE). Int J Biochem Cell Biol 2003; 35: 769-73.
11. Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem 2009; 7: 234-50.
12. Miura K, Takahashi K, Fukuchi Y. Role of biochemical markers in sarcoidosis. Nihon Rinsho 2002; 60: 1741-6.
13. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
14. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin- converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-8.
15. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40.
16. Sekhri V, Sanal S, DeLorenzo LJ, Aronow WS, Maguire GP. Cardiac sarcoidosis: A comprehensive review. Arch Med Sci 2011; 7: 546-54.
17. Solecki L. Skazenie srodowiska pracy i bytowania w rolnictwie [Polish]. IMW, Lublin 2005.
18. Nazimek L, Solecki T. Chemiczne zagrozenia w rolnictwie - stan aktualny i perspektywy [Polish]. IMW, Lublin 2006.
19. GUS. Portal informacyjny. Access: 07.12.2014. Available at: http://stat.gov.pl/.
20. Głowny inspektorat ochrony srodowiska. Stan srodowiska w wojewodztwie lubelskim. Access 07.12.2014. Available at: http://www.gios.gov.pl/.
21. Camos S, Cruz MJ, Morell F, Sole E. Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample. Clin Chem Lab Med 2012; 50: 1749-53.
22. Gentry JT, Nitowsky HM, Michael MJ. Studies on the epidemiology of sarcoidosis in the United States: The relationship to soil areas and to urban-rural residence. J Clin Invest 1955; 34: 1839-56.
23. Douglas AC. Sarcoidosis in Scotland. Am Rev Respir Dis 1961; 84: 143-7.
24. Cummings MM, Dunner E, Williams JH Jr. Epidemiologic and clinical observations in sarcoidosis. Ann Intern Med 1959; 50: 879-90.
25. Kreider ME, Christie JD, Thompson B, et al. Environmental exposures and the clinical phenotype of sarcoidosis. Chest 2005; 128: 207-15.
26. Costabel U, Bross KJ, Guzman J, Nilles A, Ruhle KH, Matthys H. Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis. Ann NY Acad Sci 1986; 465: 418-26.
27. Drent M, Wagenaar SS, Mulder PH, Van Velzen-Blad H, Diamant M, Van den Bosch JM. Bronchoalveolar lavagefluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences. Chest 1994; 105: 514-9.
28. Ward K, O'Connor C, Odlum C, Fitzgerald MX. Prognostic value of bronchoalveolar lavage in sarcoidosis: The critical influence of disease presentation. Thorax 1989; 44: 6-12.
29. Danila E, Jurgauskiene L, Malickaite R. BAL fluid cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosis. Adv Med Sci 2008; 53: 228-33.
30. Verstraeten A, Demedts M, Verwilghen J, et al. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest 1990; 98: 560-7.
31. Drent M, van Velzen-Blad H, Diamant M, Hoogsteden HC, van den Bosch JM. Relationship between presentation of sarcoidosis and T lymphocyte profile. A study in bronchoalveolar lavage fluid. Chest 1993; 104: 795-800.
32. McGrath DS, Foley PJ, Petrek M, et al. Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med 2001; 164: 197-201.
33. Sari G, Kurt E, Saydam F, Degirmenci I, Gunes HV. Association between I/D polymorphism in the ACE gene and sarcoidosis in Turkish patients. Cytotechnology 2014; 10: DOI:10.1007/s10616-014-9747-7.
34. Yilmaz D, Karkucak M, Coskun F, Yakut T, Uzaslan EK. ACE gene I/D polymorphism and risk of sarcoidosis development in Turkish patients. Tuberk Toraks 2012; 60: 201-6.
35. Salobir B, Medica I, Tercelj M, Kastrin A, Sabovic M, Peterlin B. Association of angiotensin-converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients. Med Sci Monit 2007; 13: 538-42.
36. Maliarik MJ, Rybicki BA, Malvitz E, et al. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998; 158: 1566-70.
37. Song GG, Kim JH, Lee YH. Associations between the angiotensin converting enzyme insertion/deletion polymorphism and susceptibility to sarcoidosis: A meta-Analysis. J Renin Angiotensin Aldosterone Syst 2013: DOI:10.1177/1470320313489059.
38. Rakowska J, Wojewodzka-Wiewiorska A. Zroznicowanie przestrzenne obszarow wiejskich w Polsce - stan i perspektywy rozwojuw kontekscie powiazan funkcjonalnych. Ekspertyza wykonana na zamowienie Ministerstwa Rozwoju Regionalnego [Polish]. Warsaw 2010].